4
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0001209191-24-003031
10% owner sold 1,000 shares at $0.64 ($640)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Atlas Venture Fund XI, L.P. 10% owner | 2024-02-08 | Sale | −733 | $0.64 | $469 | 2,019,563 | D |
| Atlas Venture Fund XI, L.P. 10% owner | 2024-02-08 | Sale | −267 | $0.64 | $171 | 734,546 | I |
| Open-market sales · 1,000 sh · avg $0.64 · $640 | |||||||
Loading xslF345X05/doc4.xml…